Clinical Trials Logo

Clinical Trial Summary

1. Objectives

1. to verify effect of Korean red ginseng on cold hypersensitivity of hands and feet in women

2. to establish scientific evidence for the use of Korean red ginseng by investigating changes of infrared thermography

2. Hypothesis The hypothesis is that Korean red ginseng will reduce cold hypersensitivity of hands and feet more effectively than placebo after 8 weeks administration of interventions- Korean red ginseng or the placebo.


Clinical Trial Description

Design

- This trial is a randomized, double blind, placebo controlled trial with 80 patients.

- The trial will be implemented at Kyung Hee University Hospital at Gangdong in Seoul, Korea.

- Participants will take Korean red ginseng or placebo for 8 weeks and will be followed up during 4 weeks.

- During the administration period, 6 capsules 2 times a day (1h after breakfast and dinner) of Korean red ginseng or its placebo will be provided. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01664156
Study type Interventional
Source The Korean Society of Ginseng
Contact
Status Completed
Phase Phase 4
Start date October 2012
Completion date March 2014

See also
  Status Clinical Trial Phase
Withdrawn NCT06460194 - Treatment of Frostbite Sequelae With Botulinum Toxin A Phase 2
Completed NCT03083522 - Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and Feet Phase 3
Completed NCT03374345 - Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT) Phase 2/Phase 3
Completed NCT02645916 - Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands Phase 4
Completed NCT03790033 - Efficacy and Safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet-Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial Phase 2/Phase 3